Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Anti-Obesity Prescription Drugs market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Anti-Obesity Prescription Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Anti-Obesity Prescription Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Novo Nordisk
VIVUS
Orexigen Therapeutics
Arena Pharmaceuticals
F Hoffmann La Roche
By Type:
Bupropion and Naltrexone
Orlistat
Lorcaserin
Phentermine and Topiramate
Liraglutide
By End-User:
Hospitals Pharmacies
Retail Pharmacies
E-commerce
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Anti-Obesity Prescription Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 China Anti-Obesity Prescription Drugs Market Size and Growth Rate of Bupropion and Naltrexone from 2016 to 2027
-
1.3.2 China Anti-Obesity Prescription Drugs Market Size and Growth Rate of Orlistat from 2016 to 2027
-
1.3.3 China Anti-Obesity Prescription Drugs Market Size and Growth Rate of Lorcaserin from 2016 to 2027
-
1.3.4 China Anti-Obesity Prescription Drugs Market Size and Growth Rate of Phentermine and Topiramate from 2016 to 2027
-
1.3.5 China Anti-Obesity Prescription Drugs Market Size and Growth Rate of Liraglutide from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Anti-Obesity Prescription Drugs Market Size and Growth Rate of Hospitals Pharmacies from 2016 to 2027
-
1.4.2 China Anti-Obesity Prescription Drugs Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
1.4.3 China Anti-Obesity Prescription Drugs Market Size and Growth Rate of E-commerce from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Anti-Obesity Prescription Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Anti-Obesity Prescription Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of Bupropion and Naltrexone
-
3.4.2 Market Size and Growth Rate of Orlistat
-
3.4.3 Market Size and Growth Rate of Lorcaserin
-
3.4.4 Market Size and Growth Rate of Phentermine and Topiramate
-
3.4.5 Market Size and Growth Rate of Liraglutide
4 Segmentation of Anti-Obesity Prescription Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Anti-Obesity Prescription Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Anti-Obesity Prescription Drugs in Hospitals Pharmacies
-
4.4.2 Market Size and Growth Rate of Anti-Obesity Prescription Drugs in Retail Pharmacies
-
4.4.3 Market Size and Growth Rate of Anti-Obesity Prescription Drugs in E-commerce
5 Market Analysis by Regions
-
5.1 China Anti-Obesity Prescription Drugs Production Analysis by Regions
-
5.2 China Anti-Obesity Prescription Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Anti-Obesity Prescription Drugs Landscape Analysis
-
6.1 North China Anti-Obesity Prescription Drugs Landscape Analysis by Major Types
-
6.2 North China Anti-Obesity Prescription Drugs Landscape Analysis by Major End-Users
7 Central China Anti-Obesity Prescription Drugs Landscape Analysis
-
7.1 Central China Anti-Obesity Prescription Drugs Landscape Analysis by Major Types
-
7.2 Central China Anti-Obesity Prescription Drugs Landscape Analysis by Major End-Users
8 South China Anti-Obesity Prescription Drugs Landscape Analysis
-
8.1 South China Anti-Obesity Prescription Drugs Landscape Analysis by Major Types
-
8.2 South China Anti-Obesity Prescription Drugs Landscape Analysis by Major End-Users
9 East China Anti-Obesity Prescription Drugs Landscape Analysis
-
9.1 East China Anti-Obesity Prescription Drugs Landscape Analysis by Major Types
-
9.2 East China Anti-Obesity Prescription Drugs Landscape Analysis by Major End-Users
10 Northeast China Anti-Obesity Prescription Drugs Landscape Analysis
-
10.1 Northeast China Anti-Obesity Prescription Drugs Landscape Analysis by Major Types
-
10.2 Northeast China Anti-Obesity Prescription Drugs Landscape Analysis by Major End-Users
11 Southwest China Anti-Obesity Prescription Drugs Landscape Analysis
-
11.1 Southwest China Anti-Obesity Prescription Drugs Landscape Analysis by Major Types
-
11.2 Southwest China Anti-Obesity Prescription Drugs Landscape Analysis by Major End-Users
12 Northwest China Anti-Obesity Prescription Drugs Landscape Analysis
-
12.1 Northwest China Anti-Obesity Prescription Drugs Landscape Analysis by Major Types
-
12.2 Northwest China Anti-Obesity Prescription Drugs Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Novo Nordisk
-
13.1.1 Novo Nordisk Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 VIVUS
-
13.2.1 VIVUS Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Orexigen Therapeutics
-
13.3.1 Orexigen Therapeutics Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Arena Pharmaceuticals
-
13.4.1 Arena Pharmaceuticals Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 F Hoffmann La Roche
-
13.5.1 F Hoffmann La Roche Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Anti-Obesity Prescription Drugs Market Size and Growth Rate of Bupropion and Naltrexone from 2016 to 2027
-
Figure China Anti-Obesity Prescription Drugs Market Size and Growth Rate of Orlistat from 2016 to 2027
-
Figure China Anti-Obesity Prescription Drugs Market Size and Growth Rate of Lorcaserin from 2016 to 2027
-
Figure China Anti-Obesity Prescription Drugs Market Size and Growth Rate of Phentermine and Topiramate from 2016 to 2027
-
Figure China Anti-Obesity Prescription Drugs Market Size and Growth Rate of Liraglutide from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Anti-Obesity Prescription Drugs Market Size and Growth Rate of Hospitals Pharmacies from 2016 to 2027
-
Figure China Anti-Obesity Prescription Drugs Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
Figure China Anti-Obesity Prescription Drugs Market Size and Growth Rate of E-commerce from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Anti-Obesity Prescription Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Anti-Obesity Prescription Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Anti-Obesity Prescription Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Anti-Obesity Prescription Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Bupropion and Naltrexone
-
Figure Market Size and Growth Rate of Orlistat
-
Figure Market Size and Growth Rate of Lorcaserin
-
Figure Market Size and Growth Rate of Phentermine and Topiramate
-
Figure Market Size and Growth Rate of Liraglutide
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Anti-Obesity Prescription Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Anti-Obesity Prescription Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals Pharmacies
-
Figure Market Size and Growth Rate of Retail Pharmacies
-
Figure Market Size and Growth Rate of E-commerce
-
Table China Anti-Obesity Prescription Drugs Production by Regions
-
Table China Anti-Obesity Prescription Drugs Production Share by Regions
-
Figure China Anti-Obesity Prescription Drugs Production Share by Regions in 2016
-
Figure China Anti-Obesity Prescription Drugs Production Share by Regions in 2021
-
Figure China Anti-Obesity Prescription Drugs Production Share by Regions in 2027
-
Table China Anti-Obesity Prescription Drugs Consumption by Regions
-
Table China Anti-Obesity Prescription Drugs Consumption Share by Regions
-
Figure China Anti-Obesity Prescription Drugs Consumption Share by Regions in 2016
-
Figure China Anti-Obesity Prescription Drugs Consumption Share by Regions in 2021
-
Figure China Anti-Obesity Prescription Drugs Consumption Share by Regions in 2027
-
Table North China Anti-Obesity Prescription Drugs Consumption by Types from 2016 to 2027
-
Table North China Anti-Obesity Prescription Drugs Consumption Share by Types from 2016 to 2027
-
Figure North China Anti-Obesity Prescription Drugs Consumption Share by Types in 2016
-
Figure North China Anti-Obesity Prescription Drugs Consumption Share by Types in 2021
-
Figure North China Anti-Obesity Prescription Drugs Consumption Share by Types in 2027
-
Table North China Anti-Obesity Prescription Drugs Consumption by End-Users from 2016 to 2027
-
Table North China Anti-Obesity Prescription Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure North China Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2016
-
Figure North China Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2021
-
Figure North China Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2027
-
Table Central China Anti-Obesity Prescription Drugs Consumption by Types from 2016 to 2027
-
Table Central China Anti-Obesity Prescription Drugs Consumption Share by Types from 2016 to 2027
-
Figure Central China Anti-Obesity Prescription Drugs Consumption Share by Types in 2016
-
Figure Central China Anti-Obesity Prescription Drugs Consumption Share by Types in 2021
-
Figure Central China Anti-Obesity Prescription Drugs Consumption Share by Types in 2027
-
Table Central China Anti-Obesity Prescription Drugs Consumption by End-Users from 2016 to 2027
-
Table Central China Anti-Obesity Prescription Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2016
-
Figure Central China Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2021
-
Figure Central China Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2027
-
Table South China Anti-Obesity Prescription Drugs Consumption by Types from 2016 to 2027
-
Table South China Anti-Obesity Prescription Drugs Consumption Share by Types from 2016 to 2027
-
Figure South China Anti-Obesity Prescription Drugs Consumption Share by Types in 2016
-
Figure South China Anti-Obesity Prescription Drugs Consumption Share by Types in 2021
-
Figure South China Anti-Obesity Prescription Drugs Consumption Share by Types in 2027
-
Table South China Anti-Obesity Prescription Drugs Consumption by End-Users from 2016 to 2027
-
Table South China Anti-Obesity Prescription Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South China Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2016
-
Figure South China Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2021
-
Figure South China Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2027
-
Table East China Anti-Obesity Prescription Drugs Consumption by Types from 2016 to 2027
-
Table East China Anti-Obesity Prescription Drugs Consumption Share by Types from 2016 to 2027
-
Figure East China Anti-Obesity Prescription Drugs Consumption Share by Types in 2016
-
Figure East China Anti-Obesity Prescription Drugs Consumption Share by Types in 2021
-
Figure East China Anti-Obesity Prescription Drugs Consumption Share by Types in 2027
-
Table East China Anti-Obesity Prescription Drugs Consumption by End-Users from 2016 to 2027
-
Table East China Anti-Obesity Prescription Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure East China Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2016
-
Figure East China Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2021
-
Figure East China Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2027
-
Table Northeast China Anti-Obesity Prescription Drugs Consumption by Types from 2016 to 2027
-
Table Northeast China Anti-Obesity Prescription Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Anti-Obesity Prescription Drugs Consumption Share by Types in 2016
-
Figure Northeast China Anti-Obesity Prescription Drugs Consumption Share by Types in 2021
-
Figure Northeast China Anti-Obesity Prescription Drugs Consumption Share by Types in 2027
-
Table Northeast China Anti-Obesity Prescription Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast China Anti-Obesity Prescription Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2016
-
Figure Northeast China Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2021
-
Figure Northeast China Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2027
-
Table Southwest China Anti-Obesity Prescription Drugs Consumption by Types from 2016 to 2027
-
Table Southwest China Anti-Obesity Prescription Drugs Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Anti-Obesity Prescription Drugs Consumption Share by Types in 2016
-
Figure Southwest China Anti-Obesity Prescription Drugs Consumption Share by Types in 2021
-
Figure Southwest China Anti-Obesity Prescription Drugs Consumption Share by Types in 2027
-
Table Southwest China Anti-Obesity Prescription Drugs Consumption by End-Users from 2016 to 2027
-
Table Southwest China Anti-Obesity Prescription Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2016
-
Figure Southwest China Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2021
-
Figure Southwest China Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2027
-
Table Northwest China Anti-Obesity Prescription Drugs Consumption by Types from 2016 to 2027
-
Table Northwest China Anti-Obesity Prescription Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Anti-Obesity Prescription Drugs Consumption Share by Types in 2016
-
Figure Northwest China Anti-Obesity Prescription Drugs Consumption Share by Types in 2021
-
Figure Northwest China Anti-Obesity Prescription Drugs Consumption Share by Types in 2027
-
Table Northwest China Anti-Obesity Prescription Drugs Consumption by End-Users from 2016 to 2027
-
Table Northwest China Anti-Obesity Prescription Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2016
-
Figure Northwest China Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2021
-
Figure Northwest China Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Novo Nordisk
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk
-
Figure Sales and Growth Rate Analysis of Novo Nordisk
-
Figure Revenue and Market Share Analysis of Novo Nordisk
-
Table Product and Service Introduction of Novo Nordisk
-
Table Company Profile and Development Status of VIVUS
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of VIVUS
-
Figure Sales and Growth Rate Analysis of VIVUS
-
Figure Revenue and Market Share Analysis of VIVUS
-
Table Product and Service Introduction of VIVUS
-
Table Company Profile and Development Status of Orexigen Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orexigen Therapeutics
-
Figure Sales and Growth Rate Analysis of Orexigen Therapeutics
-
Figure Revenue and Market Share Analysis of Orexigen Therapeutics
-
Table Product and Service Introduction of Orexigen Therapeutics
-
Table Company Profile and Development Status of Arena Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arena Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Arena Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Arena Pharmaceuticals
-
Table Product and Service Introduction of Arena Pharmaceuticals
-
Table Company Profile and Development Status of F Hoffmann La Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann La Roche
-
Figure Sales and Growth Rate Analysis of F Hoffmann La Roche
-
Figure Revenue and Market Share Analysis of F Hoffmann La Roche
-
Table Product and Service Introduction of F Hoffmann La Roche
-
